VERU INC. Marketing and Advertising Expense
VERU INC. (VERU) reported Marketing and Advertising Expense of $23.64 thousand for the 3-month period ending 2017-12-31, per its 10-Q filed 2018-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:MarketingAndAdvertisingExpense · last filed 2018-02-14
- VERU INC. marketing and advertising expense for the quarter ending 2017-12-31 was $23.64K, a 31.77% increase year-over-year.
- VERU INC. marketing and advertising expense for the quarter ending 2016-12-31 was $17.94K.
- VERU INC. marketing and advertising expense for the quarter ending 2011-09-30 was -$212.59K.
- VERU INC. marketing and advertising expense for the quarter ending 2011-06-30 was $114.23K, a 200.37% increase year-over-year.
- VERU INC. marketing and advertising expense for fiscal 2017 was $54.27K, a 38.93% decline from fiscal 2016.
- VERU INC. marketing and advertising expense for fiscal 2016 was $88.87K.
- VERU INC. marketing and advertising expense for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- VERU INC. marketing and advertising expense for fiscal 2014 was $58.12K, a 73.79% decline from fiscal 2013.
| Period end | Marketing and Advertising Expense 3 month | Marketing and Advertising Expense 6 month | Marketing and Advertising Expense 9 month | Marketing and Advertising Expense 12 month | Marketing and Advertising Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $23.64K 10-Q · filed 2018-02-14 | ||||
| 2017-09-30 | $54.27K 10-K · filed 2018-01-02 | ||||
| 2016-12-31 | $17.94K 10-Q · filed 2018-02-14 | ||||
| 2016-09-30 | $88.87K 10-K · filed 2018-01-02 | ||||
| 2015-09-30 | $0.00 10-K · filed 2018-01-02 | ||||
| 2014-09-30 | $58.12K 10-K · filed 2016-12-12 | ||||
| 2013-09-30 | $221.72K 10-K · filed 2015-12-02 | ||||
| 2012-09-30 | $52.95K 10-K · filed 2014-12-02 | ||||
| 2011-09-30 | -$212.59K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | -$98.36K derived: sum of 2 quarters · filed 2013-12-03 | $32.86K 10-K · filed 2013-12-03 | $332.76K 10-K · filed 2011-12-02 | |
| 2011-06-30 | $114.23K 10-Q · filed 2011-08-05 | $245.44K 10-Q · filed 2011-08-05 | |||
| 2010-09-30 | -$120.48K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | -$82.45K derived: sum of 2 quarters · filed 2012-12-04 | $76.71K 10-K · filed 2012-12-04 | $220.18K 10-K · filed 2011-12-02 | |
| 2010-06-30 | $38.03K 10-Q · filed 2011-08-05 | $197.19K 10-Q · filed 2011-08-05 | |||
| 2009-09-30 | $191.15K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |